BROOKE STIDHAM: Open Payments
NPI 1134450497 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,596 in 101 payments from 19 companies in 2025. Trend: 2023 $1,881 · 2024 $2,488 · 2025 $1,596
Food & beverage: $1,596
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 20 | $249 |
| GENZYME CORPORATION | 13 | $204 |
| ABBVIE INC. | 19 | $166 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $151 |
| PFIZER INC. | 7 | $142 |
| Lilly USA, LLC | 4 | $92 |
| Amgen Inc. | 4 | $83 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| Regeneron Healthcare Solutions, Inc. | 3 | $74 |
| LEO Pharma Inc. | 3 | $67 |
Products named: Sotyktu, DUPIXENT, CIBINQO, ILUMYA, SKYRIZI, TALTZ, OTEZLA, ADBRY.
Industry payments across TX — which companies pay providers there.
